Immunodeficiency

Primary immunodeficiencies (PIDs), also known as inborn errors of immunity (IEI) are a group of more than 400 potentially serious disorders that can lead to frequent or severe infections, swellings and autoimmune problems. PID/IEI discorders can be caused by defects in genes that control the immune system, and may be inherited.  

Information for Patients and Carers

Fast Facts abour PID/IEI 

Common Variable Immunodeficiency (CVID) Updated October 2021

 

Immunoglobulin Replacement Therapy (IRT) Updated October 2021

Primary Immunodeficiency (Inborn Errors of Immunity) Updated October 2021

Severe Combined Immunodeficiency (SCID) Updated October 2021

Subcutaneous Immunoglobulin (SCIg) Therapy - General Information Updated August 2021

Subcutaneous Immunoglobulin (SCIg) Therapy - Equipment Checklist

Subcutaneous Immunoglobulin (SCIg) Therapy - Infusion Checklist

Information for Health Professionals

ASCIA Position Statement - Immunoglobulin Replacement Therapy (IRT) in Primary Immunodeficiency (PID) New September 2021

ASCIA Immunodeficiency Strategy for Australia and New Zealand 

References - Immunodeficiency 

References - Hereditary Angioedema (HAE) 

ASCIA Webinar - HAE

ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE) 

References - Hereditary Angioedema (HAE)

ASCIA Clinical Update - Primary Immunodeficiencies (PID) 

ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg) 

ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital 

ASCIA Guidelines for Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline

ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT

ASCIA SCIg Treatment Plan 

ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 

ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy 

ASCIA ID Register How to access information (available to Members Only)

Content updated November 2021

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.